These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Association of aldosterone synthase gene -344T/C polymorphism with plasma aldosterone and angiotensin II concentration in hypertensive patients]. Hu BC, Chu SL, Wang JG, Wang ZH, Wang GL, Gao PJ, Zhu DL. Zhonghua Yi Xue Za Zhi; 2006 Apr 25; 86(16):1144-7. PubMed ID: 16796847 [Abstract] [Full Text] [Related]
4. [Associations between aldosterone synthase gene polymorphisms and left ventricular structure and function in Chinese normal Han People]. Rao L, Zhang Q, Liang W, Huang M, Zhang L. Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan 25; 34(1):70-1, 74. PubMed ID: 15600184 [Abstract] [Full Text] [Related]
7. Lack of association of angiotensin-converting enzyme and angiotensinogen genes polymorphisms with left ventricular structure in young normotensive men. Linhart A, Sedlácek K, Jáchymová M, Jindra A, Beran S, Vondrácek V, Heller S, Horký K. Blood Press; 2000 Jan 25; 9(1):47-51. PubMed ID: 10854008 [Abstract] [Full Text] [Related]
8. [Association study between a polymorphism of aldosterone synthetase gene and the pathogenesis of polycystic ovary syndrome]. Zhao SP, Tang XM, Shao DH, Dai HY, Dai SZ. Zhonghua Fu Chan Ke Za Zhi; 2003 Feb 25; 38(2):94-7. PubMed ID: 12783697 [Abstract] [Full Text] [Related]
9. Aldosterone synthase (CYP11B2) C-344T polymorphism affects the association of age-related changes of the serum C-reactive protein. Oki K, Yamane K, Satoh K, Nakanishi S, Yamamoto H, Kohno N. Hypertens Res; 2010 Apr 25; 33(4):326-30. PubMed ID: 20094057 [Abstract] [Full Text] [Related]
10. Aldosterone synthase gene polymorphism as a determinant of atrial fibrillation in patients with heart failure. Amir O, Amir RE, Paz H, Mor R, Sagiv M, Lewis BS. Am J Cardiol; 2008 Aug 01; 102(3):326-9. PubMed ID: 18638595 [Abstract] [Full Text] [Related]
12. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy. Schjoedt KJ, Lajer M, Andersen S, Tarnow L, Rossing P, Parving HH. Scand J Clin Lab Invest; 2006 Aug 01; 66(3):173-80. PubMed ID: 16714246 [Abstract] [Full Text] [Related]
13. [Study on association between aldosterone synthase gene polymorphism and the left ventricular structure and function of patients with dilated cardiomyopathy in China]. Rao L, Zhou B, Wang B, Wang YP, Li YB, Zhang L. Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov 01; 35(6):809-11. PubMed ID: 15573760 [Abstract] [Full Text] [Related]
14. MDR1 genotype-dependent regulation of the aldosterone system in humans. Zolk O, Jacobi J, Pahl A, Fromm MF, Schmieder RE. Pharmacogenet Genomics; 2007 Feb 01; 17(2):137-44. PubMed ID: 17301693 [Abstract] [Full Text] [Related]
16. Cardiac aldosterone in subjects with hypertrophic cardiomyopathy. Chai W, Hoedemaekers Y, van Schaik RH, van Fessem M, Garrelds IM, Saris JJ, Dooijes D, ten Cate FJ, Kofflard MM, Danser AH. J Renin Angiotensin Aldosterone Syst; 2006 Dec 01; 7(4):225-30. PubMed ID: 17318792 [Abstract] [Full Text] [Related]
17. Lack of association of G-protein subunit gene C825T polymorphism with left ventricular hypertrophy in essential hypertension. Shlyakhto EV, Shwartz EI, Nefedova YB, Zukova AV, Vinnic TA, Konrady AO. Med Sci Monit; 2002 May 01; 8(5):CR337-40. PubMed ID: 12011775 [Abstract] [Full Text] [Related]
18. Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension. Tsukada K, Ishimitsu T, Teranishi M, Saitoh M, Yoshii M, Inada H, Ohta S, Akashi M, Minami J, Ono H, Ohrui M, Matsuoka H. J Hum Hypertens; 2002 Nov 01; 16(11):789-93. PubMed ID: 12444540 [Abstract] [Full Text] [Related]
19. Influence of CYP11B2 gene polymorphism on the prevalence of hypertension and the blood pressure in Japanese men: interaction with dietary salt intake. Song Y, Miyaki K, Araki J, Zhang L, Takahashi Y, Nakayama T, Muramatsu M. J Nutrigenet Nutrigenomics; 2008 Nov 01; 1(5):252-8. PubMed ID: 19776632 [Abstract] [Full Text] [Related]
20. Influence of angiotensinogen and angiotensin-converting enzyme polymorphisms on cardiac hypertrophy and improvement on maximal aerobic capacity caused by exercise training. Alves GB, Oliveira EM, Alves CR, Rached HR, Mota GF, Pereira AC, Rondon MU, Hashimoto NY, Azevedo LF, Krieger JE, Negrão CE. Eur J Cardiovasc Prev Rehabil; 2009 Aug 01; 16(4):487-92. PubMed ID: 19404196 [Abstract] [Full Text] [Related] Page: [Next] [New Search]